In Recognition of Sepsis Awareness Month, Magnolia Medical Intensifies Efforts to Combat the Clinical and Economic Risks of Sepsis Misdiagnosis
SEATTLE, Sept. 7, 2023 /PRNewswire/ -- Magnolia Medical Technologies, Inc., the inventors of the Steripath® Initial Specimen Diversion Device® (ISDD®) and the ISDD market, is intensifying efforts to combat sepsis misdiagnosis this Sepsis Awareness Month. In recognition of the far-reaching implications of an inaccurate sepsis test result, including the risk of accelerating antimicrobial resistance (AMR), the company is committed to raising awareness through peer-reviewed scientific data and programmatic education.
- "Sepsis is not just a medical emergency; it's a societal crisis that exacts a terrible toll on patients and the healthcare system, alike.
- Sepsis Awareness Month is of particular significance to Magnolia Medical.
- This is a critical issue that requires immediate attention," said Tammy Johnson, AVP, Clinical Strategy at Magnolia Medical.
- Magnolia Medical is sponsoring a webinar at the 2023 Sepsis Alliance Summit , titled "State of Sepsis Awareness 2023," on September 28th.